Navigation Links
Novavax Announces Board of Director Changes
Date:10/1/2009

ROCKVILLE, Md., Oct. 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Stanley Erck has been appointed to the board's corporate governance, compensation and finance committees, replacing board chairman John Lambert on the finance committee and board member James Tananbaum who is retiring from the board. Mr. Erck has previously served as CEO of several vaccine and immunology products companies and joined the Novavax board in June 2009.

John Lambert stated: "Our board's membership and responsibilities are continuing to evolve as Novavax matures as an operating company and advances its vaccine candidates toward commercialization. We thank Jim for his three and a half years of service to our company and appreciate Stan's willingness to take on additional responsibilities which reflect his experience in vaccine development and the biopharmaceutical industry."

Dr. Tananbaum commented: "I have greatly enjoyed my affiliation with Novavax and am impressed with the company's recent progress. VLP technology is proving to be a valuable platform for vaccine development and I wish the team continued success in the years ahead."

About Novavax

Novavax is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenues, operating expenses, cash burn, and clinical developments and anticipated
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
2. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
3. Novavax Reports Second Quarter 2009 Financial Results
4. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
5. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
6. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
7. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
8. Novavax Announces Repayment of $5 Million of Convertible Debt
9. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
10. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
11. Novavax Appoints Stanley Erck to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013  The Lindsley F. Kimball Research Institute ... is a Grand Challenges Explorations winner, an initiative ... Dr. Sara Lustigman , Head of the ... and development research project, titled Innovative 3-D in ... are needed to screen drugs to help eliminate onchocerciasis (river ...
(Date:5/21/2013)... 21, 2013 The congress of ... Association) is the biggest congress in Europe ... 10,000 participants are in Istanbul ... findings. New pioneering studies have been presented: ... (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
(Date:5/21/2013)... 2013  Personal Genome Diagnostics Inc. (PGDx), today ... and expertise in genomic analysis of defined cancer ... with Blueprint Medicines.  PGDx is an innovator in ... in tumors, and Blueprint Medicines is an expert ... genetically defined patient population. "This collaboration ...
Breaking Biology Technology:New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3
... , , , ... With the introduction of the Pwo Master, Roche Applied,Science now offers a new, ... the highest possible fidelity during PCR,synthesis. , ... Pwo Master is a premixed double-concentrated formulation,that contains PwoSUPER YIELD DNA Polymerase,a new ...
... , , ... , , , , ... specific method for the detection and quantitation,of mRNA species. The assay ... (SP6, T7,and T3). These enzymes possess several properties that,make them well ...
... , ... , , , Deoxynucleotides are ... the results of your experiments. , ... Roche Applied Science developed a new manufacturing and purification,process for deoxynucleotides. ...
Cached Biology Technology:Pwo Master*:,Simplify Setup of Your Proofreading PCRs 2Pwo Master*:,Simplify Setup of Your Proofreading PCRs 3RNase Protection Assay (RPA),Using DIG-Labeled RNA Probes 2
(Date:5/21/2013)... University of Michigan Water Center today awarded 12 ... Lakes restoration and protection efforts. , The two-year ... projects, including efforts to track the remediation of ... to control non-native weedy plant invasions; study chromosomal ... responses to restoration activities. , The grants were ...
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Fueling fitness on the final frontier 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... an invasive vine that is spreading across the southeastern United ... of the pollutant surface ozone, according to a study published ... of the National Academy of Sciences . Kudzu, a ... chemicals isoprene and nitric oxide, which, when combined with nitrogen ...
... than at any time in the previous 1,500 years, a ... Nature Geoscience . The rise in temperature ... productivity of the lake, which hosts the second-largest inland fishery ... fish from Lake Tanganyika as a crucial source of protein," ...
... satellite data and Google Earth, a Purdue University researcher ... logging in what is designated as a protected United ... studies the Mount Paekdu Biosphere Reserve, a 326,000-acre forest ... to visit North Korea, Shao studies changes in the ...
Cached Biology News:Invasive kudzu is major factor in surface ozone pollution, study shows 2Twentieth-century warming in Lake Tanganyika is unprecedented 2Twentieth-century warming in Lake Tanganyika is unprecedented 3NASA, Google data show North Korea logging in protected area 2
... C 19 H 9 Br 4 NaO ... Form: Powder Clarity of Solution: Passes test ... Yellow pH 4.6 - Blue Applications: ... and acrylamide gel electrophoresis. Used in the ...
tracking dye in electrophoresis; free acid, C 19 H 10 BrO 5 S; MW: 669.96...
Denhardt's Solution is a mixture of blocking agents used in membrane-based hybridization protocols. The solution contains 1% Ficoll (type 400) 1% polyvinylpyrrolidone and 1% bovine serum albumin. Ste...
... Labeling Kit provides a unique signal amplification ... targets, including cell-surface receptors and subcellular structures. ... the patented ELF 97 phosphatase substrate, which ... the site of enzymatic activity a ...
Biology Products: